Livongo health, inc. (LVGO)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Sep'18Jun'18
Revenue

0

-

-

-

0

-

-

Revenue

-

-

0

0

-

0

0

Cost of revenue

54,403

46,158

40,503

33,013

0

0

0

Gross profit

152,551

124,040

97,890

74,703

0

0

0

Operating expenses:
Research and development

54,845

49,842

43,883

31,622

0

0

0

Sales and marketing

91,072

78,060

67,364

51,576

0

0

0

General and administrative

57,408

55,676

48,406

38,721

0

0

0

Change in fair value of contingent consideration

253

843

1,011

956

0

0

0

Total operating expenses

203,578

184,421

160,664

122,875

0

0

0

Loss from operations

-51,027

-60,381

-62,774

-48,172

0

0

0

Other income, net

4,595

3,742

2,561

1,481

0

0

0

Loss before provision for income taxes

-46,432

-56,639

-60,213

-46,691

0

0

0

Income Tax Expense (Benefit)

52

-1,369

-1,382

-1,381

0

0

0

Net Income (Loss) Attributable to Parent

-46,472

-55,270

-58,843

-45,322

0

0

0

Temporary Equity, Accretion to Redemption Value, Adjustment

55

96

138

165

0

0

0

Net loss attributable to common stockholders

-46,527

-55,366

-58,981

-45,487

0

0

0

Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)

-0.06

0.73

-0.27

-0.76

-0.79

-0.64

-0.38

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)

95,543

94,400

72,197

18,916

18,207

16,538

16,238